로딩 중…
지수 로딩 중…
Structure Therapeutics Inc.
GPCR· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$44.51-1.09%
2026-06-18
Price Chart
Structure Therapeutics Inc.+105.87%
Financials
No data
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $3.16B |
| Revenue | $0.00 |
| Net Income | $-171M |
| Total Assets | $1.51B |
| Net Assets | $1.45B |
| Value | |
| P/B | 2.19x |
| FCF Yield | -5.03% |
| Profitability | |
| ROE | -11.79% |
| ROA | -11.31% |
| Financial Health | |
| Debt Ratio | 4.22% |
| Total Debt | $6M |
| FCF | $-159M |
| Cash | $316M |
| Current Ratio | 26.16x |
| Performance | |
| 1Y Return | 105.87% |
| 1M Return | 24.05% |
| From 52W High | -53.10% |
| 1Y MDD | -61.74% |
| Trading | |
| Volume | 1,100,376 shares |
| Trading Value | $50M |
| Per Share | |
| EPS | $-2.39 |
| BPS | $25.62 |